SCHEMBL6504723

SCHEMBL6504723

COc1ccc(/C=C/C(=O)N2CCC(C(=O)NC(C)C(=O)O)CC2)c(Cl)c1Cl

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 9/20 0.54
ITGB2 P05107 7/20 0.54
ICAM1 P05362 7/20 0.54
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
APOBEC3A P31941 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
KDM4E B2RXH2 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
CAPN1 P07384 2/20 0.43
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.41
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6504728 1.00 ITGAL (0.54) ITGALITGB2ICAM1NPC1RAB9A
SCHEMBL6498445 0.93 ITGAL (0.51) ITGALITGB2ICAM1NPC1RAB9A
SCHEMBL6498439 0.93 ITGAL (0.51) ITGALITGB2ICAM1NPC1RAB9A
SCHEMBL6494678 0.92 ITGAL (0.52) ITGALITGB2ICAM1NPC1RAB9A
SCHEMBL6495217 0.92 ITGAL (0.52) ITGALITGB2ICAM1NPC1RAB9A
SCHEMBL8296246 0.92 ITGAL (0.52) ITGALITGB2ICAM1NPC1RAB9A
SCHEMBL6504517 0.90 ITGAL (0.48) ITGALITGB2ICAM1NPC1RAB9A
SCHEMBL8298731 0.90 ITGAL (0.48) ITGALITGB2ICAM1NPC1RAB9A
SCHEMBL6504520 0.90 ITGAL (0.48) ITGALITGB2ICAM1NPC1RAB9A
SCHEMBL6496667 0.89 ITGAL (0.45) ITGALITGB2ICAM1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed